XFOR · ISSUER CIK 1501697
X4 Pharmaceuticals, Inc
Between Aug 1, 2026 and Oct 29, 2026, 3 X4 Pharmaceuticals, Inc insiders reported $12K of open-market purchases and $354K of sales on SEC Form 4. The largest buyer was Craig Adam R (Executive Chairman, Director), with $12K.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 3 sales were reported under a 10b5-1 plan.
$12KInsider buying
$354KInsider selling
−$342KNet open-market
Oct 19, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 202616:06 | Oct 16, 2026 | XFOR | Executive Chairman, Director | P · Buy | $2.58 | +4,600 | 333,251 | +1% | +$12K | -44.3% | +30.1% |
| Oct 5, 202616:03 | Oct 1, 2026 | XFOR | Chief Financial Officer | S · Sell | $2.86 | −11,767 | 155,983 | -7% | −$34K | ||
| Aug 13, 202616:13 | Aug 12, 2026 | XFOR | President | S · Sell | $4.44 | −24,576 | 265,305 | -8% | −$109K | ||
| Aug 13, 202616:10 | Aug 12, 2026 | XFOR | Executive Chairman, Director | S · Sell | $4.44 | −47,436 | 328,651 | -13% | −$211K |